Eli Lilly Pledges $15M To Infectious Disease Research Institute To Continue Lilly TB Drug Discovery Initiative
GeekWire: Eli Lilly commits $15 million to fund TB drug discovery through Seattle-based initiative
“The Seattle-based Infectious Disease Research Institute (IDRI), a product-focused nonprofit that fights infectious diseases around the world, announced [Thursday] that it will receive $15 million from pharmaceutical giant Eli Lilly to continue its work in developing drugs to treat tuberculosis. … The newest commitment is a continuation of the Lilly TB Drug Discovery Initiative, a public-private partnership between the two organizations founded in 2007 and headquartered in Seattle…” (McGrane, 11/3).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.